ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Vertex Pharmaceuticals

Include trials that are no longer recruiting patients.

2 studies were found.
1.RecruitingMerimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Conditions: Hepatitis C; Hepatitis
2.No longer recruitingVX-710, Doxorubicin, and Vincristine in Treating Patients With Recurrent Small Cell Lung Cancer
Conditions: intermediate type small cell lung cancer; Recurrent Small Cell Lung Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act